comparemela.com

Latest Breaking News On - Gemcitabine cisplatin - Page 1 : comparemela.com

Dr Guru Sonpavde on the Potential of Nivolumab Plus Chemotherapy in Urothelial Carcinoma

Guru Sonpavde, MD, medical director of genitourinary oncology at the AdventHealth Cancer Institute, discussed the promising findings of the CheckMate 901 trial exploring the potential of nivolumab plus gemcitabine-cisplatin in advanced urothelial carcinoma.

Christopherk glanzAdventhealth cancer instituteBladder cancer researchGuru sonpavdeGemcitabine cisplatin

#VisualAbstract: Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma

Click to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2

Bryan sunMinute medicine incAdvanced urothelial carcinomaGemcitabine cisplatinNivolumab plus gemcitabine cisplatineUrothelial carcinomaUrothelial carcinoma treatment

First-Line Treatment Options for Patients With Metastatic Urothelial Carcinoma

Switching their focus to the metastatic urothelial carcinoma treatment landscape, panelists identify cornerstone frontline treatment options.

Urothelial carcinomasLine treatment optionsPatients with metastatic urothelial carcinomaBladder cancerUrothelial cancerUrothelial carcinomaMetastatic urothelial carcinomaCisplatin therapyCisplatin eligibilityCisplatin eligibleCisplatin ineligibleFrontline therapyFirst line therapyFirst line treatmentGemcitabine cisplatinDose dense mvac

Evolving Neoadjuvant Treatment Strategies in Muscle-Invasive Bladder Cancer

Expert perspectives on the evolving role of neoadjuvant therapy in muscle-invasive bladder cancer (MIBC) with considerations for mainstay regimens.

Urothelial carcinomasNeoadjuvant treatment strategiesMuscle invasive bladderBladder cancerUrothelial cancerUrothelial carcinomaNeoadjuvant therapyNeoadjuvant treatmentBladder preservationDose dense mvacGemcitabine cisplatinCisplatin eligibilityNeoadjuvant chemotherapyUpper tract cancer

vimarsana © 2020. All Rights Reserved.